Security key
00972D105
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)
CUSIP: 00972D105
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 270,093,163
- Total 13F shares
- 101,696,315
- Share change
- -15,809,843
- Total reported value
- $141,404,652
- Put/Call ratio
- 67%
- Price per share
- $1.39
- Number of holders
- 168
- Value change
- -$23,301,073
- Number of buys
- 68
- Number of sells
- 81
Report period
Q1 2026
Institutions
168
Top holders
10
AKBA full security history
Previous quarter: Q4 2025
Akebia Therapeutics, Inc. SEC filings
Akebia Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00972D105
Recent filing periods:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.2%
from 13D/G
|
19,318,452
|
$31,102,707 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.3%
from 13D/G
|
13,687,561
|
$22,036,973 | — | 31 Dec 2025 | |
| Muneer A. Satter |
13D/G
|
Satter Muneer A |
2.6%
|
5,747,906
|
$13,105,226 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.9%
|
16,016,448
|
$25,786,481 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
6,277,177
|
$10,107,969 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.7%
|
4,706,437
|
$7,577,364 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
4,665,537
|
$7,511,515 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
3,593,133
|
$5,784,944 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.1%
|
2,990,767
|
$4,815,135 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.9%
|
2,436,203
|
$3,922,287 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
2,313,233
|
$3,724,304 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.84%
|
2,257,411
|
$3,634,432 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.81%
|
2,199,747
|
$3,539,000 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
2,180,820
|
$3,511,120 | — | 31 Dec 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.74%
|
2,000,000
|
$3,220,000 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.61%
|
1,653,469
|
$2,662,085 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.6%
|
1,619,336
|
$2,607,000 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.58%
|
1,571,012
|
$2,528,891 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.48%
|
1,291,172
|
$2,078,787 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.45%
|
1,228,816
|
$1,978,394 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.45%
|
1,223,027
|
$1,969,073 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.42%
|
1,125,638
|
$1,812,277 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.35%
|
941,657
|
$1,516,067 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.34%
|
923,507
|
$1,486,847 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.32%
|
871,534
|
$1,403,170 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.29%
|
786,465
|
$1,266,209 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.28%
|
753,906
|
$1,213,789 | — | 31 Dec 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.28%
|
752,106
|
$1,214,651 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.27%
|
730,409
|
$1,175,958 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.26%
|
704,020
|
$1,132,896 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.26%
|
691,584
|
$1,113,451 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.25%
|
669,190
|
$1,077,395 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
666,907
|
$1,073,720 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.24%
|
657,812
|
$1,059,077 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.24%
|
647,713
|
$1,042,818 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
646,679
|
$1,041,153 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.22%
|
592,991
|
$954,716 | — | 31 Dec 2025 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.18%
|
498,961
|
$803,327 | — | 31 Dec 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
498,623
|
$802,783 | — | 31 Dec 2025 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
496,700
|
$799,687 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.17%
|
472,485
|
$760,701 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.15%
|
415,988
|
$669,741 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.15%
|
399,949
|
$643,918 | — | 31 Dec 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.14%
|
376,564
|
$606,268 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.12%
|
325,890
|
$524,683 | — | 31 Dec 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.12%
|
322,900
|
$519,869 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.12%
|
319,797
|
$514,874 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
317,419
|
$511,035 | — | 31 Dec 2025 | |
| Aquatic Capital Management LLC |
13F
|
Company |
0.11%
|
294,285
|
$473,799 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.11%
|
285,765
|
$460,082 | — | 31 Dec 2025 |
Institutional Holders of Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) as of Q1 2026
As of 31 Mar 2026,
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,696,315 shares.
The largest 10 holders included
BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, CITIGROUP INC, BANK OF AMERICA CORP /DE/, Qube Research & Technologies Ltd, MILLENNIUM MANAGEMENT LLC, and VANGUARD PORTFOLIO MANAGEMENT LLC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
165
Q1 2026 holders
168
Holder diff
3
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.